AAcclaro Medical provides the UltraClear Laser, a specialized aesthetic laser system designed for skin rejuvenation. It uses a cold fiber fractionated laser beam that creates tiny treated zones in the skin, reducing heat damage to surrounding tissue. This approach aims to stimulate collagen remodeling and improve issues like fine lines, wrinkles, sun and age spots, scars (including acne scars), and large pores. By delivering energy in small, controlled columns, the procedure minimizes pain and downtime while being suitable for most skin types. The company sells these laser devices to dermatologists, cosmetic surgeons, and medical spas, and it also earns revenue from ongoing maintenance and consumables. Compared with other aesthetic lasers, UltraClear emphasizes lower discomfort, shorter recovery, and strong safety and efficacy across diverse patients. The overall goal is to expand access to effective, safer skin rejuvenation with fast recovery in the global dermatology market.
Work here?Claim your company
Industries
Company Size
51-200
Company Stage
Series B
Total Funding
$23M
Headquarters
Smithfield, RI
Founded
2018
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$23M
Below
Industry Average
Funded Over
1 Rounds
Industry standards
Acclaro Medical is showcasing its AuraLux 2910 nm Fiber Laser at the American MedSpa Association's annual meeting at Wynn Las Vegas from 9-12 April 2026. An evolution of the company's UltraClear platform, AuraLux delivers skin rejuvenation treatments safe for all skin types with minimal discomfort and faster recovery. The device offers four treatment modalities—3DMIRACL, REFRESH, RENEW and GLIDE—targeting concerns from pigmentation and fine lines to wrinkles and scars. Using CoolPulse technology, it deposits ultrafast micro pulses for greater comfort and noticeable results. Acclaro has introduced Practice Development Managers who work alongside providers to drive practice growth and patient care. Founded in 2018, the company focuses on developing aesthetic medical solutions emphasising safety and efficacy across all skin types.
Acclaro Medical has raised $23 million in Series B funding, led by Accelmed Partners with a $20 million investment and $3 million from 3E Bioventures Capital. This funding will support the growth of Acclaro's 2910 nm fiber laser technology, including products like UltraClear® and AuraLux™, and aid in global market expansion and new product development.
~ Next-Generation AuraLux Innovates Cold Fiber Laser Technology for Physician and MedSpa Practices Seeking Pioneering Preventative and Rejuvenation Treatments with Superior Safety, Less Discomfort and Minimal Downtime While Offering Practice Growth OpportunitiesSMITHFIELD, R.I., April 10, 2025 /PRNewswire/ -- Acclaro Medical today announced the launch of AuraLux™ cold fiber laser, an evolution of its successful 2910 nm laser technology, specifically developed as an exclusive treatment solution for total skin health and timeless youth across all aesthetic practices and patient demographics. AuraLux will be unveiled at The Medical Spa Show to be held at the Wynn Las Vegas on April 10-13, 2025, and hosted by the American MedSpa Association, a leading multi-faceted national organization for the medical spa industry
"This clearance underpins our commitment to addressing the unmet needs of patients living with pigmentation disorders by improving upon the current treatment paradigm of acids, peels and passé devices," said Shlomo Assa, Co-Founder and President, Chief Technology Officer of Acclaro Medical. "Whether troubled by benign brown lesions or red discoloration, patients can now experience UltraClear's proven ability to rejuvenate their physical appearance with excellent results, reduced discomfort, minimal downtime and very limited risk.""Any change in skin tone can be concerning or upsetting," noted Dr. Erica Linnell, Founder MD of Linnell Dermatology and Aesthetics, Seattle, WA. "With the heightened awareness of skin cancer checks and an aging population, we have seen a corresponding rise in patient visits for evaluation and treatment of their pigmented lesions. The expanded regulatory indication for the UltraClear fiber laser now paves the way for us to resurface and make a difference in improving pigmentation issues with just one to two treatments."At the upcoming SCALE meeting in Nashville, TN, on May 16-19, 2024, key opinion leaders will showcase the effectiveness and versatility of UltraClear to treat a vast array of aesthetic skin conditions, ranging from the early signs of aging, facial wrinkles and crinkles around the eyes to unwanted pigmentation, the effects of gravity and scars, including acne, surgical and traumatic scars. By stimulating new cell growth leading to collagen and elastin remodeling, UltraClear treatment produces smoother and healthier-looking skin with minimal medical downtime
SMITHFIELD, R.I., March 29, 2024 /PRNewswire/ -- Acclaro Medical announced that its UltraClear® 2910 nm fiber laser was awarded the "Best Laser Treatment for All Skin Tones - 2024" from NewBeauty Magazine. The win in this highly regarded and very popular publication is a repeat favorite for the second year in a row, having secured the coveted award for UltraClear laser in 2023.The World's First Cold Fractional Ablative Fiber Laser (PRNewsfoto/Acclaro Medical Corporation)Helen Fang, Acclaro Medical's Chief Executive Officer, said, "We are thrilled to receive this prestigious 2024 NewBeauty honor and retain our leadership in the category of laser treatments for all skin types. "The award underscores UltraClear's exceptional commitment to advancing inclusivity in anti-aging care, notably by elevating safety and efficacy standards for patients with diverse skin tones, making these treatments accessible to a wider spectrum of individuals."UltraClear® is FDA-cleared and designed to successfully solve the most vital aesthetic needs of patients of all skin types, improving facial lines, wrinkles, sun damage, age spots, and scars with less pain and minimal to no downtime. The first high-speed, cold ablative 2910 nm fiber laser for total facial rejuvenation, UltraClear treats multiple skin layers—from stratum corneum to epidermis to mid dermis—to help reverse the signs of aging and effects of gravity. It vaporizes the outer layers of dull, damaged skin and heats the underlying skin layers with precisely controlled thermal energy. This causes the skin to heal and restructure, growing new skin cells and increasing collagen and elastin production
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs
Industries
Company Size
51-200
Company Stage
Series B
Total Funding
$23M
Headquarters
Smithfield, RI
Founded
2018
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs